Donor major histocompatibility complex class I expression determines the outcome of prenatal transplantation

Journal of Pediatric Surgery

Volumn 43, Issue 6, 2008, Pages 1142-1147

  Durkin, Emily T ^a   Jones, Kelly A ^a   Elnaggar, Dina ^a   Shaaban, Aimen F ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Allogeneic; Hematopoiesis; In utero transplantation; MHC class I; Mice

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL GROWTH; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEPATOCYTE TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IN UTERO STEM CELL TRANSPLANTATION; LIVING DONOR; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRENATAL PERIOD; PRIORITY JOURNAL; RECIPIENT;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FETAL TISSUE TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; LIVER; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; PREGNANCY; PREGNANCY, ANIMAL; PROBABILITY; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 44949149227     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2008.02.046     Document Type: Article

References (24)

1. Flake A.W., Roncarolo M.G., Puck J.M., et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 335 (1996) 1806-1810
2. Wengler G.S., Lanfranchi A., Frusca T., et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 348 (1996) 1484-1487
3. Flake A.W., and Zanjani E.D. In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 94 (1999) 2179-2191
4. Peranteau W.H., Endo M., Adibe O.O., et al. Evidence for an immune barrier after in utero hematopoietic-cell transplantation. Blood 109 (2007) 1331-1333
5. Shaaban A.F., Kim H.B., Gaur L., et al. Prenatal transplantation of cytokine-stimulated marrow improves early chimerism in a resistant strain combination but results in poor long-term engraftment. Exp Hematol 534 (2006) 1278-1287
6. Muench M.O., Pott Bartsch E.M., Chen J.C., et al. Ontogenic changes in CD95 expression on human leukocytes: prevalence of T-cells expressing activation markers and identification of CD95-CD45RO+ T-cells in the fetus. Dev Comp Immunol 27 (2003) 899-914
7. Kim H.B., Shaaban A.F., Milner R., et al. In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy. J Pediatr Surg 34 (1999) 726-729 [discussion 729-730]
8. Kim H.B., Shaaban A.F., Yang E.Y., et al. Microchimerism and tolerance after in utero bone marrow transplantation in mice. J Surg Res 77 (1998) 1-5
9. Westgren M. In utero stem cell transplantation. Semin Reprod Med 24 (2006) 348-357
10. Wolpert E.Z., Petersson M., Chambers B.J., et al. Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells. Proc Natl Acad Sci U S A 94 (1997) 11496-11501
11. Zhao Y., Ohdan H., Manilay J.O., et al. NK cell tolerance in mixed allogeneic chimeras. J Immunol 170 (2003) 5398-5405
12. Manilay J.O., Waneck G.L., and Sykes M. Altered expression of Ly-49 receptors on NK cells developing in mixed allogeneic bone marrow chimeras. Int Immunol 10 (1998) 1943-1955
13. Grzywacz B., Kataria N., Sikora M., et al. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood 108 (2006) 3824-3833
14. Dorfman J.R., and Raulet D.H. Acquisition of Ly49 receptor expression by developing natural killer cells. J Exp Med 187 (1998) 609-618
15. Lian R.H., Maeda M., Lohwasser S., et al. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro. J Immunol 168 (2002) 4980-4987
16. Kim S., Iizuka K., Kang H.S., et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 3 (2002) 523-528
17. Raulet D.H. Development and tolerance of natural killer cells. Curr Opin Immunol 11 (1999) 129-134
18. Veinotte L.L., Wilhelm B.T., Mager D.L., et al. Acquisition of MHC-specific receptors on murine natural killer cells. Curr Opin Immunol 23 (2003) 251-266
19. Fraser K.P., Gays F., Robinson J.H., et al. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. Eur J Immunol 32 (2002) 868-878
20. Manoussaka M., Georgiou A., Rossiter B., et al. Phenotypic and functional characterization of long-lived NK cell lines of different maturational status obtained from mouse fetal liver. J Immunol 158 (1997) 112-119
21. Manoussaka M.S., Smith R.J., Conlin V., et al. Fetal mouse NK cell clones are deficient in Ly49 expression, share a common broad lytic specificity, and undergo continuous and extensive diversification in vitro. J Immunol 160 (1998) 2197-2206
22. Toomey J.A., Shrestha S., de la Rue S.A., et al. MHC class I expression protects target cells from lysis by Ly49-deficient fetal NK cells. Eur J Immunol 28 (1998) 47-56
23. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
24. Ruggeri L., Capanni M., Casucci M., et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94 (1999) 333-339